Pitfalls in the Neuroimaging of Malignant Glioma in the Era of Antiangiogenic and Immuno/Targeted Therapy - Detecting Illusive Disease, Defining Response.

Articles

EDITORIAL

Published on 03 Jul 2017

Editorial: Pitfalls in the Neuro-Imaging of Glioblastoma in the Era of Antiangiogenic and Immune-Targeted Therapy—Detecting Elusive Disease, Defining Response

ORIGINAL RESEARCH

Published on 02 Aug 2016

Technical Pitfalls of Signal Truncation in Perfusion MRI of Glioblastoma

PERSPECTIVE

Published on 28 Jul 2016

Amino Acid PET – An Imaging Option to Identify Treatment Response, Posttherapeutic Effects, and Tumor Recurrence?

OPINION

Published on 24 Apr 2015

Follow-Up Imaging: Molecular Imaging is Likely Best as a Single Modality, but Multimodality Imaging is the Future

REVIEW

Published on 23 Feb 2015

Pitfalls in the Neuroimaging of Glioblastoma in the Era of Antiangiogenic and Immuno/Targeted Therapy – Detecting Illusive Disease, Defining Response

Share on

Frontiers in Neurology

Submit your idea

Articles

Editorial: Pitfalls in the Neuro-Imaging of Glioblastoma in the Era of Antiangiogenic and Immune-Targeted Therapy—Detecting Elusive Disease, Defining Response

Technical Pitfalls of Signal Truncation in Perfusion MRI of Glioblastoma

Amino Acid PET – An Imaging Option to Identify Treatment Response, Posttherapeutic Effects, and Tumor Recurrence?

Follow-Up Imaging: Molecular Imaging is Likely Best as a Single Modality, but Multimodality Imaging is the Future

Pitfalls in the Neuroimaging of Glioblastoma in the Era of Antiangiogenic and Immuno/Targeted Therapy – Detecting Illusive Disease, Defining Response

Frontiers in Neurology